Veracyte registers 3.35M shares for resale from HalioDx acquisition

VERACYTE, INC.

Filed prospectus supplement to register up to 3,347,493 shares of common stock for resale.
Shares were issued in connection with the HalioDx SAS acquisition that closed on August 2, 2021.
Opinion of counsel (Fenwick & West LLP) on legality of the registered shares attached as Exhibit 5.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.